Melanoma Research Alliance

📍 Washington, United States🗓 Founded 2007👥 21 employees💰 Last funded May 2014
The Melanoma Research Alliance (MRA) is the largest private funder of melanoma research. Since its founding in 2007, MRA has committed $143 million in funding to advance our understanding of this disease. MRA funds projects in the areas of prevention, diagnosis, and treatment, with the majority of funding allocated for melanoma treatment. Due to the ongoing support of our founders, 100% of every donation to MRA supports melanoma research. The mission of the Melanoma Research Alliance is to accelerate the pace of scientific discovery and its translation into effective options for patients -- in prevention, diagnosis, prognosis, and treatment -- in order to eliminate suffering and death due to melanoma.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2007
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Melanoma Research Alliance?
Melanoma Research Alliance has 2 investors on record on gritt.io and 2 late-stage investors.
When did Melanoma Research Alliance last raise funding?
The most recent investment in Melanoma Research Alliance recorded on gritt.io was in May 2014.
When was Melanoma Research Alliance founded?
Melanoma Research Alliance was founded in 2007.
What industry is Melanoma Research Alliance in?
Melanoma Research Alliance operates in Non-profit Organizations. Find similar Non-profit Organizations investors on gritt.io.
Where is Melanoma Research Alliance based?
Melanoma Research Alliance is headquartered in Washington, United States.